Spinal Bupivacaine/Morphine in laparoscopic gastro-intestinal surgery

Spinal Bupivacaine/Morphine in laparoscopic gastro-intestinal surgery - Spinal bupivacaine/morphine in laparoscopic surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON41666

Enrollment

Registered

2013-07-31

Start date

2014-08-01

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-operative pain wound pain

Interventions

A single spinal shot of bupivacaine/morphine

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Laparoscopic Gastro-intestinal surgery

Exclusion criteria

Exclusion criteria: Bariatric surgery, rectal surgery, kidney-failure, Aorta-valve stenosis, coagulation disorders, emergency surgery

Design outcomes

Primary

Measure	Time frame
elective laparoscopic gastro-intestinal surgery in adults	—

Secondary

Measure	Time frame
Opioid-use in the post-operative phase, side-effects of opioids, mobilisation, , patient-satisfactory, difficulty of surgery, compliance of the abdominal wall during surgery and NK-cell activity	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)